In terms of biological function, interfering with DARS2 expression can inhibit the proliferation, invasion, and migration of BLCA, while overexpression of DARS2 has been demonstrated to promote the malignant progression of tumors. This evidence concerns the gene DARS2 and bladder transitional cell carcinoma.